Effect of estrogen replacement therapy on lipids. Implications for cardiovascular risk.
Estrogen administration lowers low-density-lipoprotein cholesterol levels and raises high-density-lipoprotein cholesterol levels; those effects are associated with a diminished risk of atherosclerotic cardiovascular disease. Because of adverse effects on the endometrium, estrogen is commonly given in combination with a progestogen. Progestogens have adverse effects on plasma lipoproteins, though, and the beneficial effects of estrogen may be neutralized when a progestogen is added. Data on lipoprotein effects of hormone replacement therapy in postmenopausal women are scarce, and further study is needed.